Oracle's 5-year credit default swap premium hit 2.03%, the highest since 2008, as AI investment concerns intensified. Korean retail investors shifted to 3x leveraged ETFs SOXL and TQQQ after regulators announced a 30 million won minimum deposit for single-stock leveraged ETFs. Samcheondang Pharmaceutical fell 29.79% one day after hitting daily limit up, triggering investment caution status.
Oracle CDS Premium Reaches Record High Amid AI Investment Concerns
Oracle's 5-year credit default swap premium climbed to 2.03%, marking the highest level since statistical tracking began in 2008. The surge followed the emergence of China's Moonshot AI startup 'Kimi K3' model, which demonstrated performance comparable to major US AI models, raising questions about the return on investment for big tech's large-scale AI spending. Oracle's corporate bond spreads widened across the board. S&P Global Ratings downgraded Oracle's credit rating earlier this month, citing financial burden from expanded AI investments. Morgan Stanley assessed that while Oracle faces minimal immediate risk of downgrade from investment grade to speculative grade, medium-term prospects depend on AI investment execution and monetization results.
Korean Investors Shift to SOXL and TQQQ Following Leverage ETF Regulation
The Financial Services Commission announced regulations raising the minimum deposit for single-stock leveraged ETFs to 30 million won, prompting investors to move capital to overseas index-type and sector-type leveraged ETFs excluded from the regulation. Following the regulatory announcement, SOXL, which tracks the semiconductor index with 3x leverage, rose to the number one position in net purchases of overseas stocks by domestic retail investors. TQQQ, tracking the Nasdaq 100 index with 3x leverage, jumped to second position. Both products had remained outside the top 50 net purchases before the regulation announcement. The financial investment industry expects the measure will create a balloon effect, with funds moving to unregulated products rather than reducing overall leveraged investment demand.
Samcheondang Pharmaceutical Drops 29.79% After Daily Limit Up
Samcheondang Pharmaceutical plunged 29.79% to near the daily limit down, one day after hitting the daily limit up. Questions emerged regarding the substance of the previous day's FDA-related positive news, and market distrust grew after the company refused to disclose the original document citing trade secrets. The Korea Exchange designated Samcheondang Pharmaceutical as an investment caution stock due to concentrated trading by a small number of accounts, with the top 10 buying accounts accounting for 41.50% of trading volume over the past three days. Compared to its late March peak when it held the KOSDAQ leadership position, the stock price has fallen 86.4%.
FAQ
What caused Oracle's credit default swap premium to reach its highest level since 2008?
Oracle's 5-year CDS premium hit 2.03% due to growing concerns about big tech AI investment returns after China's Moonshot AI 'Kimi K3' model showed performance comparable to major US models. S&P Global Ratings downgraded Oracle's credit rating earlier this month citing financial burden from AI investment expansion.
Why did Korean retail investors shift to SOXL and TQQQ?
The Financial Services Commission announced regulations requiring a 30 million won minimum deposit for single-stock leveraged ETFs. Investors moved to SOXL and TQQQ because these overseas index-type 3x leveraged ETFs are excluded from the new regulations, creating a balloon effect as funds shifted to unregulated products.
